ModernMedicine Resource Center More Topics

Hot Topics in Prostate Cancer

What’s new in updated brachytherapy guidelineThe update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.
Studies: PCa treatments differ in QoL outcomesTwo recent JAMA studies confirm a higher rate of sexual and urinary side effects with radical prostatectomy compared with radiation therapy and surveillance.
Single-fraction HDR BT feasible for localized PCaA definitive radiotherapy dose for localized prostate cancer can be safely administered using high-dose rate brachytherapy as a single outpatient procedure.
Mental health conditions contribute to PCa-related costsMood and adjustment disorders were strong predictors of the annual number of outpatient visits, hospital admissions, and number of days in the hospital for patients with prostate and breast cancer, according to a recent study.
mpMRI could reduce biopsies, improve diagnosisUsing multi-parametric magnetic resonance imaging to triage men with high serum PSA could save about one-fourth of patients from having transrectal ultrasound-guided prostate biopsy, according to a recent study.
Adding hormone therapy to salvage RT found efficaciousThe addition of hormonal therapy in post-RP is “practice changing,” study author says.
PCa: Emotional distress influences treatment decisionResearchers have found that the anxiety men often experience after being diagnosed with prostate cancer could lead to potentially unnecessary treatment options.
Laser-activated PCa therapy promising in phase III studyResearchers evaluate an experimental treatment called vascular-targeted photodynamic therapy in men with localized prostate cancer.
Mathematical model may predict PCa tumor growth, evolutionThe novel tool could result in earlier prostate cancer diagnoses and less invasive testing, although a prostate cancer expert cautioned that the model makes multiple assumptions and has not been validated.
Nomogram helps predict biochemical failure risk post RPUse of the nomogram, along with factors such as PSA level and family history, is a reliable, useful tool for helping urologists and their patients make better treatment decisions, says the author of a recent study.